LONRF1, short for "LON Peptidase N-Terminal Domain and Ring Finger 1," is a multifunctional protein that plays a role in various cellular processes, including protein quality control, regulation of apoptosis, and response to cellular stress. It is part of the LON family of proteins, which are conserved ATP-dependent proteases.The LONRF1 protein contains a Lon protease N-terminal domain and a RING finger domain. The Lon domain suggests a role in the selective degradation of misfolded, damaged, or regulatory proteins, a critical function in maintaining cellular homeostasis. The RING finger domain is typically associated with E3 ubiquitin ligase activity, implying a role in tagging proteins with ubiquitin for subsequent degradation by the proteasome.
LONRF1's involvement in protein quality control means it is integral to the cell's response to stressors that cause protein damage, such as oxidative stress or heat shock. By helping to clear misfolded or damaged proteins, LONRF1 contributes to the protection of cells from the toxic effects of protein aggregation.In the context of apoptosis, or programmed cell death, LONRF1 may have a regulatory function. It can interact with other proteins involved in the apoptotic pathway to modulate cell death signals, which is crucial in development, immune system functioning, and cancer suppression.The diverse functions of LONRF1 reflect the importance of fine-tuned protein regulation in cellular physiology. Disruptions in the expression or activity of LONRF1 could have significant consequences, potentially leading to disorders associated with protein aggregation, such as neurodegenerative diseases, or affecting the cell's ability to control its life cycle, which is a critical aspect of cancer biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, may impact protein degradation pathways relevant to LONRF1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, potentially influencing proteolytic processes involving LONRF1. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Specific proteasome inhibitor, could affect protein turnover related to LONRF1 function. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Irreversible proteasome inhibitor, potentially impacting LONRF1-associated pathways. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Selective and irreversible proteasome inhibitor, may influence LONRF1 function. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
Proteasome inhibitor, could indirectly modulate pathways involving LONRF1. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Proteasome inhibitor, may affect proteolytic activities related to LONRF1. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Inhibits DNA binding of transcription factors, potentially affecting transcription regulation by LONRF1. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits transcriptional activity, could indirectly influence LONRF1's role in transcription regulation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA polymerase, potentially affecting transcription processes involving LONRF1. | ||||||